Robert Marx: Stem cell leased regenerative medicine

Regenerating viable bone capable of gaining implant primary stability is paramount in dental rehabilitation today. This can be achieved without additional morbity by the effective use of autologous adult stem cells in combination with allogenic bone and recombinant human bone morphogenetic protein-2. This in-situ tissue engineering harvests stem cells from blood via platelet rich plasma or bone marrow via aspiration which are proliferated and differentiated into functional osteoblasts that deposit bone on the scaffold of allogeneic bone and fibrin which goes on to resorb the allogeneic bone and become a mature bone. This approach is applicable to all forms of ridge augmentation, sinus augmentations, cystic defects and even most continuity defects .

Robert E. Marx, DDS, Professor of Surgery and Chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine, is well known as an educator, researcher, and innovative surgeon. He has pioneered new concepts and treatments for pathologies of the oral and maxillofacial area as well as new techniques in reconstructive surgery. His many prestigious awards, including the Harry S. Archer Award, the William J. Giles Award, the Paul Bert Award, the Donald B. Osbon Award, and the Daniel Laskin Award, attest to his dedication and commitment to the field of oral and maxillofacial surgery. His textbook Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment has also won the American Medical Writers Associations Prestigious Book of the year Award and his other textbooks Platelet Rich Plasma: Dental and Craniofacial Applications, Tissue Engineering, Oral and Intravenous Bisphosphonates Induced Osteonecrosis, and an Atlas of Bone Harvesting have been best sellers. He is a section editor of Oral and Craniofacial Tissue Engineering and serves as a reviewer to many journals.